Skip to main content
Erschienen in: Indian Journal of Otolaryngology and Head & Neck Surgery 2/2024

07.01.2024 | Original Article

Minimizing the Recurrence Rate in Covid Associated Mucormycosis: Our Experience in 500 Patients

verfasst von: Anchal Kumar Jain, Yamini Gupta, Jagram Verma, Surbhi Godha, Indra Prakash Prajapati

Erschienen in: Indian Journal of Otolaryngology and Head & Neck Surgery | Ausgabe 2/2024

Einloggen, um Zugang zu erhalten

Abstract

Mucormycosis is an aggressive, fatal fungal infection. The fungal organisms are ubiquitous and easily affect immunocompromised patients. The main aim of this article is to emphasize over the knowledge of different diagnostic methods (diagnostic nasal endoscopy, ct/ contrast mri pns + orbit + brain, Wet KOH mount), the importance of practising an aggressive surgical resection, medical treatments (liposomal amphotericin B, amphotericin gel, tablet posaconazole, nasal douching, retrorbital amphotericin injection), suction cleaning and regular follow up of the patient after surgical management. This can greatly help in minimizing the recurrence of mucormycosis even in immunocompromised patients in a population. The study performed was a prospective study conducted from April 2021 to July 2021 in which we included 500 patients who presented to the OPD & Department of ENT or Emergency Department of Maharaja Yashwantrao Hospital with complaints suggestive of mucormycosis. The patients who were surgically fit were operated. Out of the 500 patients who were diagnosed with Mucormycosis, from April 2021 to July 2021 complete cure was achieved in 456 patients( 91.2%) and only 44 patients (8.8%) have shown recurrence due to various causes (specially those who did not came for regular follow up). Rhinorbital was the most common site to be involved. In the study it was found that most of the patients which showed recurrence were male, post covid and immunocompromised. Diabetes mellitus was found to be most common among immunocompromised patients. The recurrence in patients with mucormycosis can be minimise by educating the masses regarding importance of public and personal hygiene, and multidisciplinary management with regular follow up offers a better approach to treat this life-threatening condition. The study shows the importance of clinical diagnosis, concurrent surgical treatment, medical treatment, post op care, suction cleaning and regular follow up advice. It is necessary us to take the step forward in this regard, so that in the future we will be better prepared for such type of epidemic.
Literatur
1.
Zurück zum Zitat Panneerselvam K, Kumar MS, Karthikeyan, Mohan AM (2020) Recurrent mucormycosis—better understanding of treatment and management. J Fam Med Prim Care 9(12):6279–6281CrossRef Panneerselvam K, Kumar MS, Karthikeyan, Mohan AM (2020) Recurrent mucormycosis—better understanding of treatment and management. J Fam Med Prim Care 9(12):6279–6281CrossRef
2.
Zurück zum Zitat Rai S, Misra D, Misra A, Jain A, Jain P, Dhawan A (2018) Palatal mucormycosis masquerading as bacterial and fungal osteomyelitis: a rare case report. Contemp Clin Dent 9(2):309–313CrossRefPubMedPubMedCentral Rai S, Misra D, Misra A, Jain A, Jain P, Dhawan A (2018) Palatal mucormycosis masquerading as bacterial and fungal osteomyelitis: a rare case report. Contemp Clin Dent 9(2):309–313CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat Lim S, Bae JH, Kwon H-S, Nauck MA (2021) COVID-19 and diabetes mellitus: from pathophysiology to clinical management. Nat Rev Endocrinol 17(1):11–30CrossRefPubMed Lim S, Bae JH, Kwon H-S, Nauck MA (2021) COVID-19 and diabetes mellitus: from pathophysiology to clinical management. Nat Rev Endocrinol 17(1):11–30CrossRefPubMed
7.
Zurück zum Zitat Spellberg B, Edwards J, Ibrahim A (2005) Novel perspectives on mucormycosis: pathophysiology, presentation, and management. Clin Microbiol Rev 18(3):556–569CrossRefPubMedPubMedCentral Spellberg B, Edwards J, Ibrahim A (2005) Novel perspectives on mucormycosis: pathophysiology, presentation, and management. Clin Microbiol Rev 18(3):556–569CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Rammaert B, Lanternier F, Poirée S, Kania R, Lortholary O (2012) Diabetes and mucormycosis: a complex interplay. Diabetes Metab 38(3):193–204CrossRefPubMed Rammaert B, Lanternier F, Poirée S, Kania R, Lortholary O (2012) Diabetes and mucormycosis: a complex interplay. Diabetes Metab 38(3):193–204CrossRefPubMed
10.
Zurück zum Zitat Price JC, Stevens DL (1980) Hyperbaric oxygen in the treatment of rhinocerebral mucormycosis. Laryngoscope 90(5 Pt 1):737–747CrossRefPubMed Price JC, Stevens DL (1980) Hyperbaric oxygen in the treatment of rhinocerebral mucormycosis. Laryngoscope 90(5 Pt 1):737–747CrossRefPubMed
11.
Zurück zum Zitat Reed C, Bryant R, Ibrahim AS, Edwards J, Filler SG, Goldberg R et al (2008) Combination polyene-caspofungin treatment of rhino-orbital-cerebral mucormycosis. Clin Infect Dis 47(3):364–371CrossRefPubMed Reed C, Bryant R, Ibrahim AS, Edwards J, Filler SG, Goldberg R et al (2008) Combination polyene-caspofungin treatment of rhino-orbital-cerebral mucormycosis. Clin Infect Dis 47(3):364–371CrossRefPubMed
Metadaten
Titel
Minimizing the Recurrence Rate in Covid Associated Mucormycosis: Our Experience in 500 Patients
verfasst von
Anchal Kumar Jain
Yamini Gupta
Jagram Verma
Surbhi Godha
Indra Prakash Prajapati
Publikationsdatum
07.01.2024
Verlag
Springer India
Erschienen in
Indian Journal of Otolaryngology and Head & Neck Surgery / Ausgabe 2/2024
Print ISSN: 2231-3796
Elektronische ISSN: 0973-7707
DOI
https://doi.org/10.1007/s12070-023-04442-5

Weitere Artikel der Ausgabe 2/2024

Indian Journal of Otolaryngology and Head & Neck Surgery 2/2024 Zur Ausgabe

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Hörschwäche erhöht Demenzrisiko unabhängig von Beta-Amyloid

29.05.2024 Hörstörungen Nachrichten

Hört jemand im Alter schlecht, nimmt das Hirn- und Hippocampusvolumen besonders schnell ab, was auch mit einem beschleunigten kognitiven Abbau einhergeht. Und diese Prozesse scheinen sich unabhängig von der Amyloidablagerung zu ereignen.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Betalaktam-Allergie: praxisnahes Vorgehen beim Delabeling

16.05.2024 Pädiatrische Allergologie Nachrichten

Die große Mehrheit der vermeintlichen Penicillinallergien sind keine. Da das „Etikett“ Betalaktam-Allergie oft schon in der Kindheit erworben wird, kann ein frühzeitiges Delabeling lebenslange Vorteile bringen. Ein Team von Pädiaterinnen und Pädiatern aus Kanada stellt vor, wie sie dabei vorgehen.

Update HNO

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.